{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:07:48Z","timestamp":1792130868617,"version":"4.4.0"},"reference-count":11,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2002,1,4]],"date-time":"2002-01-04T00:00:00Z","timestamp":1010102400000},"content-version":"vor","delay-in-days":1130,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[1998,12]]},"abstract":"<jats:p>Idiotypic IgM expressed by B\u2010cell non\u2010Hodgkin's lymphoma (NHL) is clone specific and an ideal tumour antigen for immune targeting. We previously showed that repeated rounds of <jats:italic>in vitro<\/jats:italic> stimulation of peripheral blood mononuclear cells (PBMC) with autologous idiotypic heavy variable (VH) complementarity\u2010determining region (CDR)\u20103 peptide produced T\u2010cell lines able to proliferate, produce Th1 cytokines and kill autologous target cells pulsed with the CDR3 peptide. Furthermore, fresh autologous lymphoma cells were lysed by these T\u2010cell lines, suggesting a potential for the clinical use of the CDR3 peptide for lymphoma vaccination. In this study, we determined the specific immune responses of a patient following vaccination with VH CDR3 peptide to determine if similar immune responses observed <jats:italic>in vitro<\/jats:italic> could be elicited <jats:italic>in vivo<\/jats:italic>. The patient received three fortnightly subcutaneous injections of idiotypic CDR3 peptide. The injection sites developed inflammation after the second and third vaccinations. Peripheral blood T cells were able to proliferate and produce IFN\u2010\u03b3 upon rechallenge with the CDR3 peptide <jats:italic>in vitro<\/jats:italic>. Cytotoxic T lymphocytes (CTLs) for autologous CD3\u2010depleted CDR3\u2010pulsed PBMC were detected, but only after the first vaccination. T\u2010cell lines generated after vaccination could lyse peptide\u2010pulsed autologous target cells. We also detected the production of anti\u2010CDR3 peptide antibodies in the patient's serum. We conclude that naked CDR3 peptide vaccination can result in the generation of potentially beneficial specific immune responses as predicted by <jats:italic>in vitro<\/jats:italic> studies.<\/jats:p>","DOI":"10.1046\/j.1365-2141.1998.01036.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:07:02Z","timestamp":1047362822000},"page":"663-668","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["<i>In\u2010vivo<\/i> immune responses to idiotypic VH complementarity\u2010determining region 3 peptide vaccination in B\u2010cell non\u2010Hodgkin's lymphoma"],"prefix":"10.1111","volume":"103","author":[{"given":"Yue\u2010Jin","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seah H.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,1,4]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.4049\/jimmunol.145.3.1029","article-title":"Idiotypic vaccination against murine B cell lymphoma: humoral and cellular requirements for the full expression of antitumor immunity","volume":"145","author":"Campbell M.J.","year":"1990","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.4049\/jimmunol.141.9.3227","article-title":"Immunotherapy of established murine B cell lymphoma: combination of idiotype immunisation and cyclophosphamide","volume":"141","author":"Campbell M.J.","year":"1988","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.4049\/jimmunol.141.6.2168","article-title":"Idiotypic vaccination as a treatment for a B cell lymphoma","volume":"141","author":"George A.J.","year":"1988","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0196-52"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199210223271705"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910630622"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1993.tb03043.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/362755a0"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.4049\/jimmunol.156.10.3911","article-title":"Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor\u2010specific CTL induced by peptide vaccination can lead to the inability to reject tumor","volume":"156","author":"Toes R.E.M.","year":"1996","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_11_2","article-title":"T cells recognise the VH complementarity\u2010determining region 3 of the idiotypic protein of B cell non\u2010Hodgkin's lymphoma","volume":"27","author":"Wen Y.J.","year":"1997","journal-title":"European Journal of Immunology"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00592.x"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.1998.01036.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.1998.01036.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.1998.01036.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T00:23:37Z","timestamp":1698452617000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.1998.01036.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,12]]}},"alternative-id":["10.1046\/j.1365-2141.1998.01036.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.1998.01036.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,12]]},"assertion":[{"value":"2002-01-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}